This content is machine translated Highlights from the AAD Annual Meeting Atopic Dermatitis: Interesting News on Drug Candidates in Phase III At the 2026 Annual Meeting of the American Academy of Dermatology (AAD), the latest study data on amlitelimab and rademikibart, among other topics, were presented during Late-Breaking Research sessions. The...…
View Post 4 min This content is machine translated Cutaneous lupus erythematosus (CLE) Assessment and outlook An overview article published in 2023 summarizes current and potential future treatment strategies for CLE. It remains to be seen whether further progress in researching the pathogenetic relationships will bring…
View Post 5 min This content is machine translated Hidradenitis suppurativa Treatment options – status quo and outlook The management of hidradenitis suppurativa remains a clinical challenge. A combination of different therapeutic modalities is often required to achieve a sufficient degree of disease control. One study demonstrated that…
